BW

Barbara P. Wallner

BI Biogen: 16 patents #1 of 174Top 1%
PT Point Therapeutics: 13 patents #1 of 5Top 20%
ZO Ziopharm Oncology: 4 patents #2 of 17Top 15%
University of Michigan: 3 patents #689 of 4,352Top 20%
DI Dana-Farber Cancer Institute: 1 patents #698 of 1,343Top 55%
Overall (All Time): #103,522 of 4,157,543Top 3%
34
Patents All Time

Issued Patents All Time

Showing 25 most recent of 34 patents

Patent #TitleCo-InventorsDate
9340563 Salts of isophosphoramide mustard and analogs thereof John Amedio, Philip B. Komarnitsky 2016-05-17
8796329 Method for controlling angiogenesis in animals Philip B. Komarnitsky 2014-08-05
8604007 Salts of isophosphoramide mustard and analogs thereof John Amedio, Philip B. Komarnitsky 2013-12-10
8252773 Combination therapy with organic arsenicals Philip B. Komarnitsky 2012-08-28
7323171 Methods of treating skin conditions using inhibitors of the CD2/LFA-3 interaction Kevin D. Cooper 2008-01-29
7282484 Anti-tumor agents Glenn Miller 2007-10-16
7276371 Stimulation of hematopoietic cells in vitro William Bachovchin 2007-10-02
7265118 Regulation of substrate activity 2007-09-04
7259138 Anti-tumor agents Glenn Miller 2007-08-21
7067489 Hematopoietic stimulation Barry Jones, Glenn Miller, Sharlene Adams 2006-06-27
6979697 Regulation of substrate activity 2005-12-27
6949514 Anti-tumor agents Glenn Miller 2005-09-27
6890904 Anti-tumor agents Glenn Miller 2005-05-10
6770628 Hematopoietic stimulation Barry Jones, Glenn Miller, Sharlene Adams 2004-08-03
6764681 Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the CD2/LFA-3 interaction Kevin D. Cooper 2004-07-20
6703238 Methods for expanding antigen-specific T cells William Bachovchin 2004-03-09
6355614 Cyclic boroproline compounds 2002-03-12
6300314 Hematopoietic stimulation Barry Jones, Glenn Miller, Sharlene Adams 2001-10-09
6258597 Stimulation of hematopoietic cells in vitro William Bachovchin 2001-07-10
6162432 Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the CD2/LFA-3 interaction Kevin D. Cooper 2000-12-19
5928643 Method of using CD2-binding domain of lymphocyte function associated antigen 3 to initiate T cell activation Glenn Miller, Margaret D. Rosa 1999-07-27
5914111 CD2-binding domain of lymphocyte function associated antigen-3 Glenn Miller, Margaret D. Rosa 1999-06-22
5728677 Methods of inhibiting T-cell dependent proliferation of peripheral blood lymphocytes using the CD2-binding domain of lymphocyte function associated antigen 3 Glenn Miller, Margaret D. Rosa 1998-03-17
5547853 CD2-binding domain of lymphocyte function associated antigen 3 Glenn Miller, Margaret D. Rosa 1996-08-20
5484711 DNA sequences, recombinant DNA molecules and processes for producing lipocortins III, IV, V & VI R. Blake Pepinsky, Jeffrey Browning 1996-01-16